Acute hepatitis secondary to interferon beta-1a in multiple sclerosis.
Christopher
V
V
Scolding
N
N
Przemioslo
R T
RT
D000276:Adjuvants, Immunologic / Q000009:adverse effects* / Q000627:therapeutic use; D000328:Adult; D005260:Female; D006505:Hepatitis / Q000209:etiology*; D006801:Humans; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000009:adverse effects* / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000150:complications / Q000188:drug therapy
D000276:Adjuvants, Immunologic; D016899:Interferon-beta; D000068556:Interferon beta-1a
Neurology. 1999 Nov 10;53(8):1622-7
10563602
Neurology. 2001 May 22;56(10):1416
11376205
Neurology. 2001 Jun 26;56(12):1628-36
11425926
Drug Saf. 2003;26(11):815-27
12908850
Neurology. 2003 Jan 14;60(1):44-51
12525716
Am J Gastroenterol. 2002 Mar;97(3):767-8
11922585